2020-11-12 Legal Press releases

Interim report January – September 2020

The period in summary

Third quarter July 1 – September 30, 2020

• Our marketing authorization application for Strangvac was submitted to the European Medicines Agency, EMA, at the end of February. During the third ... Read more

2020-10-02 News

Global Product Manager for Strangvac

We have an exciting new opportunity for a Global Product Manager for our lead product Strangvac^® - a vaccine that promises to be a game changer in the fight against the equine disease ... Read more

2020-09-02 News

Intervacc to participate at ABGSC Investor Day on September 7

On Monday, September 7, Intervacc's CEO Andreas Andersson will participate in the live broadcast of ABGSC Investor Day in Stockholm. The company is in an exciting and intensive phase with, among other things, an ongoing process for a European ... Read more

2020-06-16 Legal Press releases

Intervacc has carried out a directed issue of approximately 6.5 million shares, raising gross proceeds of approximately SEK 147 million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN ... Read more

2020-06-16 Legal Press releases

Intervacc intends to carry out a directed share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE , IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN ... Read more

2020-06-15 Legal Press releases

Intervacc and the Karolinska Institutet extend contract for the development of innovative animal health vaccines

Stockholm 15 June 2020 - Intervacc AB (publ) and the Karolinska Institute, KI, announce today that they have extended the contract for the development of a new generation of animal health vaccines using recombinant ... Read more